Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist Entity disclosure reporting period:   01/01/2021 - 06/30/2021
Authorizing Officer name John F.X. Heffernan
Title Principal
Business name Park Street Strategies, LLC
Address 121 Mount Vernon Street   
City, state, zip code Boston, MA 02108         
Country US
Phone 617-981-0015 

Client Compensation
NameAmount
Massachusetts Biotechnology Council $60,000.00
Biotechnology Innovation Organization (BIO) $27,000.00
Sage Therapeutics $33,000.00
UCB, Inc. $22,500.00
Horizon Therapeutics USA, Inc. $36,000.00
PTC Therapeutics $25,000.00
Bastion Elevate $12,000.00
Total salaries received $215,500.00

 
Compensation/Salaries Paid
Lobbyist or Entity nameSalaries
John F.X. Heffernan $65,000.00
Total salaries paid $65,000.00
 
Activities, Bill Numbers and Titles
No activities, bill numbers or bill titles were disclosed for this reporting period.
 
Operating Expenses
DateRecipientType of expenseAmount
06/30/2021 Staples Photocopies, scans $15.98
06/23/2021 Apple Computer equipment, supplies $1,124.13
06/30/2021 Staples Computer equipment, supplies $52.05
02/05/2021 Amazon Computer equipment, supplies $25.47
03/19/2021 New England Council Professional dues $1,000.00
02/15/2021 Greater Boston Chamber of Commerce Professional dues $1,350.00
06/30/2021 Meeting House Office & Retail Internet fees $100.00
06/30/2021 Riley & Dever, P.C. Legal fees $1,450.00
06/30/2021 Amazon Office supplies, equipment $74.35
06/30/2021 Meeting House Office & Retail Rent $3,000.00
06/30/2021 AT&T Wireless Telephone, cell phone, handheld $630.66
  Total operating expenses $8,822.64
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
 
Lobbyist: John F.X. Heffernan
Client: UCB, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 627 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1311 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 736 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 1254 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 644 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Support $0.00 N/A
House Bill 1224 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 650 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Oppose $0.00 N/A
House Bill 1272 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Support $0.00 N/A
House Bill 201 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
Senate Bill 753 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 771 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 1278 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 1256 An Act relative to preventing discrimination against persons with disabilities in the provision of health care Support $0.00 N/A
House Bill 729 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
Senate Bill 756 An Act relative to step therapy and patient safety Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Sage Therapeutics
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 738 An Act protecting pregnant and postpartum patients Support $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 1311 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
Senate Bill 1518 An Act advancing the health of pregnant persons Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Horizon Therapeutics USA, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1311 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Bastion Elevate
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: PTC Therapeutics
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Support $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Massachusetts Biotechnology Council
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1190 An Act relating to patient cost, benefit, and coverage information, choice, and price transparency Neutral $0.00 N/A
House Bill 2096 An Act relative to the establishment of and payments into an opioid stewardship fund Oppose $0.00 N/A
Senate Bill 613 An Act protecting research animals Oppose $0.00 N/A
Senate Bill 785 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 21, 30, and 32 which extended the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1191 An Act to help patients and reduce health care costs by ensuring patient adherence to medications Neutral $0.00 N/A
House Bill 2235 An Act to improve patient access to prescription medication Neutral $0.00 N/A
Senate Bill 627 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 786 An Act to bring down the cost of prescription drugs Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 33, which authorized the re-opening of certain brick-and-mortar premises designated as Phase I workplace Neutral $0.00 N/A
House Bill 743 An Act establishing a commission to study a state-wide drug repository program Oppose $0.00 N/A
House Bill 1272 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3827 An Act relative to transferring federal funds to the federal COVID-19 response fund Neutral $0.00 N/A
Senate Bill 696 An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications Neutral $0.00 N/A
Senate Bill 1481 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
House Bill 89 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
House Bill 1202 An Act to ensure access to generic medication Neutral $0.00 N/A
House Bill 2397 An Act creating an obesity task force and pilot program Support $0.00 N/A
Senate Bill 644 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 1209 An Act relative to banning noncompetition agreements in the Commonwealth Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 , All Provider Bulletin 291 Neutral $0.00 N/A
House Bill 1069 An Act empowering health care consumers Support $0.00 N/A
House Bill 1303 An Act relative to compensation for victims of opioids Oppose $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 753 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Support $0.00 N/A
House Bill 55 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and relief to employers in the Commonwealth Neutral $0.00 N/A
House Bill 1198 An Act to ensure access to the full range of treatment options for people with obesity Support $0.00 N/A
House Bill 2325 An Act relative to pharmacy testing Neutral $0.00 N/A
Senate Bill 639 An Act relative to pharmacy benefit managers Support $0.00 N/A
Senate Bill 790 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 35, clarifying the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces Neutral $0.00 N/A
House Bill 729 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 1254 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 3787 An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth Neutral $0.00 N/A
Senate Bill 684 An Act to reduce the cost of pharmacy benefits Support $0.00 N/A
Senate Bill 1480 An Act to prevent undue influence on prescriber behavior Oppose $0.00 N/A
House Bill 1053 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1278 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 728 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
Senate Bill 1533 An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth Neutral $0.00 N/A
House Bill 60 to a study of the rules of the House Neutral $0.00 N/A
House Bill 1201 An Act ensuring access to medications Neutral $0.00 N/A
House Bill 2377 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Oppose $0.00 N/A
Senate Bill 642 An Act empowering health care consumers Support $0.00 N/A
Senate Bill 804 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289 Neutral $0.00 N/A
House Bill 1107 An Act relative to health insurer reserve requirements Neutral $0.00 N/A
House Bill 1307 An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs Oppose $0.00 N/A
Senate Bill 35 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
Senate Bill 756 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
House Bill 1059 An Act relative to patient financial protection Support $0.00 N/A
House Bill 1279 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Support $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 736 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 1915 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 90 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
House Bill 1210 An Act relative to drug prices paid by carriers Oppose $0.00 N/A
House Bill 2403 An Act to establish a sharps stewardship program Oppose $0.00 N/A
Senate Bill 647 An Act relative to health insurer reserve requirements Neutral $0.00 N/A
Senate Bill 1250 An Act relative to clarifying legislative intent regarding the non-competition law Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth (Executive Office of Health and Human Services) COVID19 Emergency Waivers - bulletins 21, 22 removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
House Bill 357 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Support $0.00 N/A
House Bill 3771 An Act providing for Massachusetts COVID-19 emergency paid sick leave Neutral $0.00 N/A
Senate Bill 664 An Act ensuring access to medications Neutral $0.00 N/A
Senate Bill 1465 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring Executive Office of Health and Human Services, Orderly Transition of Public Health Emergency Orders Issued Pursuant to Governor Baker’s State of Emergency Declared March 10, 2020 Neutral $0.00 N/A
House Bill 1123 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1311 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 38 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
Senate Bill 770 An Act relative to primary care for you Neutral $0.00 N/A
Executive Office of the Governor Monitoring March 10, Governor Baker’s – State of Emergency to respond to Covid-19 Order Neutral $0.00 N/A
House Bill 1155 An Act to ensure access to generic medications Support $0.00 N/A
House Bill 1822 An Act prohibiting body size discrimination Support $0.00 N/A
Senate Bill 215 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
Senate Bill 771 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID- Order No. 13, which designated certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people Neutral $0.00 N/A
House Bill 201 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
House Bill 1224 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 3702 An Act providing for Massachusetts COVID-19 emergency paid sick leave Neutral $0.00 N/A
Senate Bill 650 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Oppose $0.00 N/A
Senate Bill 1294 An Act strengthening prescription drug safety and drug stewardship Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring Governor Baker’s Steps for COVID-19 Vaccine Distribution Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Biotechnology Innovation Organization (BIO)
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 743 An Act establishing a commission to study a state-wide drug repository program Oppose $0.00 N/A
House Bill 1272 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3827 An Act relative to transferring federal funds to the federal COVID-19 response fund Neutral $0.00 N/A
Senate Bill 696 An Act to help patients and reduce healthcare costs by ensuring patient adherence to medications Neutral $0.00 N/A
Senate Bill 1481 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
House Bill 1053 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1278 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 4000 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 728 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
Senate Bill 1533 An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth Neutral $0.00 N/A
House Bill 55 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and relief to employers in the Commonwealth Neutral $0.00 N/A
House Bill 1198 An Act to ensure access to the full range of treatment options for people with obesity Support $0.00 N/A
House Bill 2325 An Act relative to pharmacy testing Neutral $0.00 N/A
Senate Bill 639 An Act relative to pharmacy benefit managers Support $0.00 N/A
Senate Bill 790 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 35, clarifying the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces Neutral $0.00 N/A
House Bill 1107 An Act relative to health insurer reserve requirements Neutral $0.00 N/A
House Bill 1307 An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs Oppose $0.00 N/A
Senate Bill 35 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
Senate Bill 756 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2485 Senate FY 2022 Budget Neutral $0.00 N/A
House Bill 90 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
House Bill 1210 An Act relative to drug prices paid by carriers Oppose $0.00 N/A
House Bill 2403 An Act to establish a sharps stewardship program Oppose $0.00 N/A
Senate Bill 647 An Act relative to health insurer reserve requirements Neutral $0.00 N/A
Senate Bill 1250 An Act relative to clarifying legislative intent regarding the non-competition law Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 , All Provider Bulletin 291 Neutral $0.00 N/A
House Bill 1059 An Act relative to patient financial protection Support $0.00 N/A
House Bill 1279 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Support $0.00 N/A
House Bill 4001 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 736 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 1915 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 1 An Act making appropriations for the Fiscal Year 2022 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1191 An Act to help patients and reduce health care costs by ensuring patient adherence to medications Neutral $0.00 N/A
House Bill 2235 An Act to improve patient access to prescription medication Neutral $0.00 N/A
Senate Bill 627 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 786 An Act to bring down the cost of prescription drugs Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 33, which authorized the re-opening of certain brick-and-mortar premises designated as Phase I workplace Neutral $0.00 N/A
House Bill 60 to a study of the rules of the House Neutral $0.00 N/A
House Bill 1201 An Act ensuring access to medications Neutral $0.00 N/A
House Bill 2377 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Oppose $0.00 N/A
Senate Bill 642 An Act empowering health care consumers Support $0.00 N/A
Senate Bill 804 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289 Neutral $0.00 N/A
House Bill 1069 An Act empowering health care consumers Support $0.00 N/A
House Bill 1303 An Act relative to compensation for victims of opioids Oppose $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2022 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 753 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
Senate Bill 2058 An Act designating the last day of February as rare disease day in the Commonwealth Support $0.00 N/A
House Bill 201 An Act advancing health care research and decision-making centered on patients and people with disabilities Support $0.00 N/A
House Bill 1224 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 3702 An Act providing for Massachusetts COVID-19 emergency paid sick leave Neutral $0.00 N/A
Senate Bill 650 An Act relating to patient cost, benefit and coverage information, choice, and price transparency Oppose $0.00 N/A
Senate Bill 1294 An Act strengthening prescription drug safety and drug stewardship Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth (Executive Office of Health and Human Services) COVID19 Emergency Waivers - bulletins 21, 22 removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
House Bill 89 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
House Bill 1202 An Act to ensure access to generic medication Neutral $0.00 N/A
House Bill 2397 An Act creating an obesity task force and pilot program Support $0.00 N/A
Senate Bill 644 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 1209 An Act relative to banning noncompetition agreements in the Commonwealth Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19, All Provider Bulletin 289 Neutral $0.00 N/A
House Bill 1123 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1311 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 38 An Act financing a program for improvements to the Unemployment Insurance Trust Fund and providing relief to employers and workers in the Commonwealth Neutral $0.00 N/A
Senate Bill 770 An Act relative to primary care for you Neutral $0.00 N/A
Executive Office of the Governor Monitoring March 10, Governor Baker’s – State of Emergency to respond to Covid-19 Order Neutral $0.00 N/A
House Bill 1190 An Act relating to patient cost, benefit, and coverage information, choice, and price transparency Neutral $0.00 N/A
House Bill 2096 An Act relative to the establishment of and payments into an opioid stewardship fund Oppose $0.00 N/A
Senate Bill 613 An Act protecting research animals Oppose $0.00 N/A
Senate Bill 785 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID-Order No. 21, 30, and 32 which extended the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
House Bill 357 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 1237 An Act relative to non-medical switching Support $0.00 N/A
House Bill 3771 An Act providing for Massachusetts COVID-19 emergency paid sick leave Neutral $0.00 N/A
Senate Bill 664 An Act ensuring access to medications Neutral $0.00 N/A
Senate Bill 1465 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring Governor Baker’s Steps for COVID-19 Vaccine Distribution Neutral $0.00 N/A
House Bill 729 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 1254 An Act relative to promoting comprehensive transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 3787 An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth Neutral $0.00 N/A
Senate Bill 684 An Act to reduce the cost of pharmacy benefits Support $0.00 N/A
Senate Bill 1480 An Act to prevent undue influence on prescriber behavior Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring  Executive Office of Health and Human Services, Orderly Transition of Public Health Emergency Orders Issued Pursuant to Governor Baker’s State of Emergency Declared March 10, 2020 Neutral $0.00 N/A
House Bill 1155 An Act to ensure access to generic medications Support $0.00 N/A
House Bill 1822 An Act prohibiting body size discrimination Support $0.00 N/A
Senate Bill 215 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
Senate Bill 771 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
Executive Office of the Governor Monitoring Governor Baker’s COVID- Order No. 13, which designated certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateLobbyist nameRecipient nameOffice soughtAmount
01/06/2021 John F.X. Heffernan Juan Pablo Jaramillo State Representative $200.00
02/10/2021 John F.X. Heffernan Aaron Michlewitz State Representative $200.00
02/16/2021 John F.X. Heffernan Jon Santiago State Representative $200.00
02/22/2021 John F.X. Heffernan Michael J. Rodrigues State Senate $200.00
02/24/2021 John F.X. Heffernan Nick Collins State Senate $200.00
03/09/2021 John F.X. Heffernan Adrian Madaro State Representative $200.00
03/10/2021 John F.X. Heffernan Paul Donato State Representative $200.00
03/11/2021 John F.X. Heffernan Marjorie Decker State Representative $200.00
03/11/2021 John F.X. Heffernan Mike Rush State Senate $200.00
03/29/2021 John F.X. Heffernan Karen Spilka State Senate $200.00
04/09/2021 John F.X. Heffernan Joe Boncore State Senate $200.00
04/11/2021 John F.X. Heffernan David Biele State Representative $200.00
04/13/2021 John F.X. Heffernan Bill Driscoll Jr. State Representative $200.00
04/14/2021 John F.X. Heffernan Dave Rogers State Representative $200.00
04/26/2021 John F.X. Heffernan Adam Hinds State Senate $200.00
05/04/2021 John F.X. Heffernan John Lawn State Representative $200.00
05/17/2021 John F.X. Heffernan Brendan Crighton State Senate $200.00
05/20/2021 John F.X. Heffernan Ed Coppinger State Representative $200.00
06/14/2021 John F.X. Heffernan Jerry Parisella State Representative $200.00
06/14/2021 John F.X. Heffernan Sal DiDomenico State Senate $200.00
   Total contributions $4,000.00
Close this page